• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Owlet Announces Pricing of Public Offering of Class A Common Stock

    10/22/25 12:06:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials
    Get the next $OWLT alert in real time by email

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announced the pricing of an underwritten public offering of 4,196,000 shares of the Company's Class A common stock (the "Offering"). The shares of Class A common stock are being sold at a public offering price of $7.15 per share, before underwriting discounts and commissions. All of the shares in the Offering are to be sold by the Company. The gross proceeds to Owlet from the Offering are expected to be approximately $30.0 million, before deducting underwriting discounts and commissions and other offering expenses. The Company has granted the underwriters of the Offering a 30-day option to purchase up to an additional 629,400 shares of Class A common stock at the public offering price less the underwriting discounts and commissions. The Offering is expected to close on or about October 23, 2025, subject to the satisfaction of customary closing conditions.

    Owlet intends to use the net proceeds from the Offering to support continued commercialization and research and development, and for general corporate purposes.

    William Blair and TD Cowen are acting as the joint bookrunners for the Offering. Craig-Hallum is acting as co-manager for the Offering.

    The securities described above are being offered by Owlet pursuant to an effective shelf registration statement on Form S-3 (File No. 333-281556) that was previously filed with the U.S. Securities and Exchange Commission (the "SEC") on August 14, 2024. The Offering is being made only by means of a written prospectus and prospectus supplement that form a part of the registration statement, copies of which may be obtained, when available, by request from: William Blair & Company, L.L.C., Attn: Prospectus Department, 150 North Riverside Plaza, Chicago, Illinois 60606, by telephone at 1-800-621-0687 or by email at: [email protected]; or TD Securities (USA) LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at [email protected].

    This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

    About Owlet, Inc.

    Owlet's digital health infant monitoring platform is transforming the journey of parenting. The Company (NYSE:OWLT) offers FDA-cleared medical and consumer pediatric wearables and an integrated HD visual and audio camera that provides real-time data and insights to parents who safeguard health, optimize wellness, and ensure peaceful sleep for their children.

    Since 2012, over two million parents worldwide have used Owlet's platform, contributing to one of the largest collections of consumer infant health and sleep data. The Company continues to develop software and digital data solutions to bridge the current healthcare gap between hospital and home and bring new insights to parents and caregivers globally. Owlet believes that every child deserves to live a long, happy, and healthy life.

    Forward-Looking Statements

    This press release contains forward-looking statements. All statements other than statements of historical facts contained herein, including, without limitation, statements regarding the completion of the Offering, the expected gross proceeds of the Offering, the anticipated use of proceeds from the Offering and the potential exercise by the underwriters of an option to purchase additional shares, are forward-looking statements reflecting the current beliefs and expectations of Owlet's management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements represent Owlet's current expectations regarding future events and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those implied by the forward-looking statements. Among those risks and uncertainties are market conditions, including market interest rates, tariffs, the trading price and volatility of Owlet's Class A common stock, the satisfaction of closing conditions related to the Offering, and risks relating to Owlet's business, including those identified in the "Risk Factors" section of Owlet's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, in its subsequent Quarterly Reports on Form 10-Q and other filings with the SEC, as well as the preliminary prospectus supplement and accompanying prospectus relating to the Offering. The forward-looking statements included in this press release speak only as of the date of this press release, and Owlet does not undertake to update the statements included in this press release for subsequent developments, except as may be required by law.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251021288128/en/

    Media Contact:

    [email protected]

    Investor Contact:

    [email protected]

    Get the next $OWLT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OWLT

    DatePrice TargetRatingAnalyst
    4/23/2025$7.00Outperform
    Northland Capital
    10/6/2021$12.00 → $5.00Neutral
    Citigroup
    10/5/2021$8.50 → $5.50Buy → Neutral
    BofA Securities
    9/8/2021$8.50Buy
    BofA Securities
    8/5/2021$11.00Neutral
    Citigroup
    More analyst ratings

    $OWLT
    SEC Filings

    View All

    SEC Form S-3 filed by Owlet Inc.

    S-3 - Owlet, Inc. (0001816708) (Filer)

    11/21/25 4:04:33 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    SEC Form S-8 filed by Owlet Inc.

    S-8 - Owlet, Inc. (0001816708) (Filer)

    11/14/25 4:35:12 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    SEC Form 10-Q filed by Owlet Inc.

    10-Q - Owlet, Inc. (0001816708) (Filer)

    11/13/25 4:34:08 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Workman Kurt was granted 80,235 shares, increasing direct ownership by 24% to 419,004 units (SEC Form 4)

    4 - Owlet, Inc. (0001816708) (Issuer)

    10/15/25 9:14:01 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Director Kim John C. was granted 107,626 shares, increasing direct ownership by 86% to 233,030 units (SEC Form 4)

    4 - Owlet, Inc. (0001816708) (Issuer)

    10/15/25 9:13:31 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Large owner Trilogy Equity Partners, Llc converted options into 686,469 shares, increasing direct ownership by 78% to 1,567,468 units (SEC Form 4)

    4 - Owlet, Inc. (0001816708) (Issuer)

    10/15/25 9:12:58 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Northland Capital initiated coverage on Owlet with a new price target

    Northland Capital initiated coverage of Owlet with a rating of Outperform and set a new price target of $7.00

    4/23/25 9:11:45 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Citigroup reiterated coverage on Owlet with a new price target

    Citigroup reiterated coverage of Owlet with a rating of Neutral and set a new price target of $5.00 from $12.00 previously

    10/6/21 12:45:24 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet downgraded by BofA Securities with a new price target

    BofA Securities downgraded Owlet from Buy to Neutral and set a new price target of $5.50 from $8.50 previously

    10/5/21 7:41:47 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Owlet and Locus Health Partner to Seamlessly Deliver Infant Health Data into Remote Patient Monitoring Programs

    This first-of-its-kind infant care collaboration for Owlet enables clinicians to access Owlet's data through Locus Health's platform, enhancing visibility, improving care continuity, and supporting families after hospital discharge. Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announces a partnership with Locus Health, a leader in remote patient monitoring, for more integrated infant health management. The collaboration connects data from Owlet's FDA-cleared prescription device, BabySat®, directly into the Locus Health platform, giving healthcare providers ongoing and secure access to vital infant health information after hospital disch

    11/19/25 8:45:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet Reports Third Quarter 2025 Financial Results

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the third quarter ended September 30, 2025. Owlet's Chief Executive Officer and President, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business and corporate update today, November 13, 2025, at 4:30 p.m. ET. Q3 2025 Financial Highlights: Record Q3 Revenue of $32.0 million, up 44.6% from Q3 2024 Record Q3 Gross Profit of $16.2 million; Q3 Gross Margin of 50.6%, down 150 basis points from Q3 2024 driven primarily by tariff impact Record Q3 Operating Income of

    11/13/25 4:16:00 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet Partners with Rhapsody to Connect Remote Baby Monitoring Data to EHRs

    Collaboration bridges home and hospital, creating a secure pathway for pediatric insights to be managed and shared. Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announces a partnership with Rhapsody, a global leader in digital health enablement and interoperability, to securely connect infant health insights from Owlet's FDA-cleared, prescription pulse oximeter, BabySat®, directly into their existing electronic health record (EHR) workflows. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112744527/en/Owlet partners with Rhapsody to securely connect infant vital signs from

    11/12/25 8:45:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Leadership Updates

    Live Leadership Updates

    View All

    Owlet Commits Critical Support To Parents and Researchers On A Mission To End SIDS

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, is on a mission to raise critical funds for research that could bring an end to sudden infant death syndrome (SIDS). Owlet is partnering in this effort with Dr. Carmel Harrington, Honorary Research Fellow at Sydney Children's Hospital Westmead, and Elisha Palmer of Knox Blocks Foundation, both of whom are parents that have lost a child to SIDS. Sudden unexpected infant death (SUID), which includes SIDS, claims the lives of more than 3,000 babies each year in the U.S. alone1. The rate of SIDS is on the rise in the U.S.2 – making it one of the leading causes of infant mortality3. Despite this, there is m

    10/2/23 8:30:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet Appoints Eclipse Partner Marc Stoll to Board of Directors

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, today announces the appointment of Marc Stoll to the Company's Board of Directors. Stoll is currently an Investment Partner at Eclipse, a strategic investment firm focused on advancing the Industrial Evolution. His experience spans more than 25 years across the global finance and technology industries, and his expertise in leading corporate strategy and operational excellence will help bolster Owlet's future ventures and growth potential. "I'm thrilled to join Owlet's Board of Directors after spending time becoming very familiar with the brand and products, its life-changing mission and amazing custome

    8/16/23 9:00:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet Appoints Healthcare Executive Melissa Gonzales to Board of Directors

    Owlet, Inc. (NYSE:OWLT, "the Company"))), the pioneer of smart baby monitoring, is pleased to announce the addition of Melissa Gonzales to the Company's Board of Directors. Gonzales brings more than 20 years of consumer and provider healthcare experience to Owlet, further advancing the Company as a leader in infant monitoring solutions. "Owlet's growth proposition to facilitate change in health equity through its innovation in connected digital monitoring is extremely exciting," said Melissa Gonzales. "Creating meaningful momentum and impact within these trends is important to me personally and professionally and I am looking forward to contributing my experience towards supporting Owlet'

    7/19/23 9:00:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Financials

    Live finance-specific insights

    View All

    Owlet Reports Third Quarter 2025 Financial Results

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the third quarter ended September 30, 2025. Owlet's Chief Executive Officer and President, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business and corporate update today, November 13, 2025, at 4:30 p.m. ET. Q3 2025 Financial Highlights: Record Q3 Revenue of $32.0 million, up 44.6% from Q3 2024 Record Q3 Gross Profit of $16.2 million; Q3 Gross Margin of 50.6%, down 150 basis points from Q3 2024 driven primarily by tariff impact Record Q3 Operating Income of

    11/13/25 4:16:00 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet to Report Third Quarter 2025 Financial Results on November 13, 2025

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, plans to announce third quarter 2025 financial results after market close on Thursday, November 13, 2025. Owlet's President and Chief Executive Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-470-1428 (domestic) or 646-844-6383 (international) and reference Access Code 428622. A simultaneous webcast may be accessed online at the Events section of Owlet's Investor Relations website at investors.owletcare.com. A replay w

    10/29/25 4:05:00 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet Reports Second Quarter 2025 Financial Results; Increases Full Year 2025 Guidance; Announces CEO Transition Plan

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the second quarter ended June 30, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business and corporate update today, August 7, 2025, at 4:30 p.m. ET. Q2 2025 Financial Highlights Q2 Revenue of $26.1 million, up 25.9% from Q2 2024 Q2 Gross Margin of 51.3%, up 180 basis points from Q2 2024 Q2 Net Loss of $37.6 million, including a $34.8 million non-cash, mark-to-market common stock w

    8/7/25 4:05:00 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Owlet Inc.

    SC 13G/A - Owlet, Inc. (0001816708) (Subject)

    10/24/24 4:05:58 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13D/A filed by Owlet Inc.

    SC 13D/A - Owlet, Inc. (0001816708) (Subject)

    8/22/24 6:39:55 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13D/A filed by Owlet Inc.

    SC 13D/A - Owlet, Inc. (0001816708) (Subject)

    8/22/24 4:25:26 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials